| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JANX | Common Stock | Purchase | $9,299,011 | +304,287 | +3.3% | $30.56 | 9,621,533 | 05 Mar 2025 | See footnotes | F1, F2, F3 |
| transaction | JANX | Common Stock | Purchase | $1,172,342 | +37,455 | +0.39% | $31.30 | 9,658,988 | 05 Mar 2025 | See footnotes | F2, F3, F4 |
| transaction | JANX | Common Stock | Purchase | $11,453,023 | +372,093 | +3.9% | $30.78 | 10,031,081 | 06 Mar 2025 | See footnotes | F2, F3, F5 |
| transaction | JANX | Common Stock | Purchase | $3,418,590 | +110,206 | +1.1% | $31.02 | 10,141,287 | 07 Mar 2025 | See footnotes | F2, F3, F6 |
| holding | JANX | Common Stock | 1,048,406 | 05 Mar 2025 | See footnotes | F2, F7 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.90 to $30.89 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. |
| F3 | Held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). |
| F4 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.90 to $31.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 to $31.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.74 to $31.40 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F7 | Held directly by the Nexus Fund II. |
Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.